chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Body pain; Low fever; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: OEN8732) via an unspecified route of administration in the left arm on 01Apr2021 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Patient had no relevant medical history. Patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not received any other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination.  The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN 6206) via an unspecified route of administration in the  left arm on 11Mar2021 at 15:00  (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 13:45, the patient experienced low grade fever and body pain. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of low grade fever and general body pain was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 02Apr2021 at 13:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and had no concomitant medications. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 14:30, the patient experienced headache. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event headache was recovering at the time of report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Cold sweat, Diarrhoea, Fatigue, Nausea, Vomiting
Clinical narrative: Nausea; vomiting; diarrhea; exhaustion; cold sweats; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 30Mar2021 at 14:00(at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history was not included. The patient did not have any allergies to medications, food, or other products. Concomitant medications included acetylsalicylic acid (BABY ASPIRIN,18mg) from unknown date for unknown indication, ascorbic acid, biotin, calcium pantothenate, cyanocobalamin, ergocalciferol, iron, nicotinamide, pyridoxine hydrochloride, retinol, riboflavin, thiamine hydrochloride, tocopheryl acetate (CENTRUM) from unknown date for unknown indication and collagen vi (MANUFACTURER UNKNOWN) from unknown date for unknown indication and multivitamin(MANUFACTURER UNKNOWN)from unknown date for unknown indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in right arm on 09Mar2021 at 14:00, as a single dose for COVID-19 immunisation.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 31Mar2021, at 16:00 the patient experienced nausea, vomiting, diarrhea, exhaustion and cold sweats for several hours. The patient did not receive any treatment for the reported events. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events nausea, vomiting, diarrhea, exhaustion and cold sweats were not resolved at the time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Got a rash on different parts of body on back and private areas; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er 8734) via an unspecified route of administration in the left arm on 01Apr2021 at 14:30 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. The patient's medical history included diabetes. Patient had allergies to medications, food, or other products which was not specific. Concomitant medications included metformin (MANUFACTURER UNKNOWN) 850 mg, lisinopril (MANUFACTURER UNKNOWN) 20 mg and simvastatin (MANUFACTURER UNKNOWN) 20 mg, all for unknown indications from  unknown dates. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 05:30, the patient got a rash on different parts of his body on his back and private areas. The event rash resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of rash and included treatment with BENADRYL which helped. The clinical outcome of the event rash was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, SARS-CoV-2 test
Clinical narrative: cervical and occipital lymph node enlargement; This is a spontaneous report from a contactable nurse. A 43-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration on 22Mar2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included infiltrating duct carcinoma of breast. The patient had no known allergies to medications, food or other products. Concomitant medication included alprazolam (MANUFACTURER UNKNOWN) of 0.5mg, from an unknown date for unknown indication. It was unknown whether the patient had received any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021, 2 days after pfizer COVID vaccine, the patient experienced cervical and occipital lymph node enlargement. On 25Mar2021, the patient underwent lab tests and procedures, which included SARS coronavirus RNA, qual, PCR test (nasal swab) and the result was negative. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the reported event. The clinical outcomes of cervical and occipital lymph node enlargement were resolved on an unknown date in 2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 24Mar2021 at 15:15 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to medications, food, or other products. Concomitant medications included cetirizine hydrochloride (ZYRTEC)  for unknown indication from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, the patient experienced fever. The patient reported that fever developed exactly 7 days after the first dose. On 31Mar2021, the patient underwent nasal swab test for COVID-19  and the result was negative. On 01Apr2021, the patient underwent nasal swab test for COVID-19 and the result was negative. The patient did not receive any treatment for the events. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event fever was resolving at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea
Clinical narrative: Still experiencing extreme nausea; Exhaustion weeks after; Headache; This is a spontaneous report from a contactable consumer, the patient. A 78-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 10Mar2021 at 15:00(at the age of 78-years-old) as a single dose for COVID-19 immunisation. Medical history included kidney pain and cancer. The patient did not have any allergies to medications, food, or other products. Concomitant medications included atorvastatin calcium (LIPITOR) and magnesium (MANUFACTURER UNKNOWN) started on unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the arm left on 16Feb2021 at 18:00 (at the age of 78-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Mar2021 the patient experienced  extreme nausea, exhaustion weeks after and headache. The patient was not a person who got nausea at all and was active normally. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event extreme nausea, exhaustion weeks after, headache was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Influenza, Pain
Clinical narrative: Body aches (especially in the neck, back, and face),; Chills; Low-grade fever (about 99-101); Headache; Mild flu; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 31Mar2021 at 11:15 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and hypothyroidism. The patient was allergic to penicillin and lamotrigine. Concomitant medications included lithium (MANUFACTURER UNKNOWN), ethinylestradiol; ferrous fumarate; norethisterone acetate (LO LOESTRIN FE), levothyroxine (MANUFACTURER UNKNOWN) and melatonin (MANUFACTURER UNKNOWN) for unknown indication and from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 09Mar2021 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine.  On 31Mar2021 at 23:30 the patient experienced body aches (especially in the neck, back, and face), chills, low-grade fever (about 99-101) and headache. The patient felt it was like a mild flu but it was bad enough and had to miss the class in the university. Therapeutic measures were taken for the reported event and included treatment with mostly acetaminophen (TYLENOL) and some ibuprofen (MANUFACTURER UNKNOWN). The adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events general body pain, chills, fever, headache and mild flu were recovering at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Body aches (especially in the neck, back, and face),; Chills; Low-grade fever (about 99-101); Headache; Mild flu; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 31Mar2021 at 11:15 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and hypothyroidism. The patient was allergic to penicillin and lamotrigine. Concomitant medications included lithium (MANUFACTURER UNKNOWN), ethinylestradiol; ferrous fumarate; norethisterone acetate (LO LOESTRIN FE), levothyroxine (MANUFACTURER UNKNOWN) and melatonin (MANUFACTURER UNKNOWN) for unknown indication and from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 09Mar2021 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine.  On 31Mar2021 at 23:30 the patient experienced body aches (especially in the neck, back, and face), chills, low-grade fever (about 99-101) and headache. The patient felt it was like a mild flu but it was bad enough and had to miss the class in the university. Therapeutic measures were taken for the reported event and included treatment with mostly acetaminophen (TYLENOL) and some ibuprofen (MANUFACTURER UNKNOWN). The adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events general body pain, chills, fever, headache and mild flu were recovering at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Heart rate increased
Clinical narrative: Sudden feeling of lightheadedness; Heart started racing; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left  arm on 02Apr2021 at 14:15 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Patient medical history was provided as no. The patient did not have any known allergies to medications, food, or other products. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 16:15, the patient had a feeling of light-headedness and patient's heart started racing, which lasted for about a minute or two. The adverse events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. No therapeutic treatment was taken for the reported events. The clinical outcome of the events feeling of lightheadedness and heart started racing was recovered on 02Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vertigo, Vomiting
Clinical narrative: Severe vertigo; Nausea; Vomiting; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Mar2021 at 17:15 (at the age of 57-years-old), as a single dose for COVID-19 immunisation. The patient did not have any medical history. Other vaccine received within 4 weeks prior to the COVID-19 vaccine included varicella zoster vaccine rge (cho) (SHINGRIX) on 05Mar2021 in the left arm. Concomitant medications included vitamin d nos (VITAMIN D) and unspecified low dose statins; both for unspecified indication from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies to medications, food or other products. On an unknown date in 2021, the patient experienced severe vertigo, nausea and vomiting. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event vertigo, nausea and vomiting was recovering at the time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Musculoskeletal stiffness, Neck pain
Clinical narrative: Chills; Headache; Arm pain; Shoulder pain; Neck pain (left side); Stiff neck (left side); Joint pain knees; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the arm left on 01Apr2021 at 11:45(at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history included heart failure and emphysema. Concomitant medications included dutasteride (AVODART), rosuvastatin calcium (CRESTOR), enalapril maleate, hydrochlorothiazide (ENALAPRIL H), metoprolol succinate (TOPROL XL) and acetylsalicylic acid (ASP); all from unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the arm left on 11Mar2021 at 13:15 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 11:45 the patient experienced Chills, Headache, Arm pain, Shoulder pain, Neck pain, Stiff neck all left side and Joint pain knees. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events Chills, Headache, Arm pain, Shoulder pain, Neck pain, Stiff neck and Joint pain knees was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Chills; Headache; Arm pain; Shoulder pain; Neck pain (left side); Stiff neck (left side); Joint pain knees; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the arm left on 01Apr2021 at 11:45(at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history included heart failure and emphysema. Concomitant medications included dutasteride (AVODART), rosuvastatin calcium (CRESTOR), enalapril maleate, hydrochlorothiazide (ENALAPRIL H), metoprolol succinate (TOPROL XL) and acetylsalicylic acid (ASP); all from unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the arm left on 11Mar2021 at 13:15 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 11:45 the patient experienced Chills, Headache, Arm pain, Shoulder pain, Neck pain, Stiff neck all left side and Joint pain knees. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events Chills, Headache, Arm pain, Shoulder pain, Neck pain, Stiff neck and Joint pain knees was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Disorientation, Sleep terror
Clinical narrative: Had a night terror; Woke up screaming and disoriented; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730), via an unspecified route of administration on 31Mar2021 at 09:30 (at the age of 17-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food or other products. Concomitant medication included OCP (oral contraceptive pills) from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 23:00, the patient had a night terror. The patient woke up screaming and disoriented. The patient ran out of the room and was screaming. The patient's mom had to "wake her up" even though it looked like the patient was awake. This had never happened before. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event night terror and woke up screaming and disoriented were resolved at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Chills, Dizziness, Heart rate increased, Nausea
Clinical narrative: Body aches; Heighten skin sensitivity; Nausea; Dizziness; Loss of balance; Elevated heart rate; Severe fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 15:00 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. Concomitant medications included drospirenone and ethinyl estradiol (GIANVI) from an unknown date for birth control. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Mar2021 at 15:00 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 02:00 the patient experienced chills, body aches, heighten skin sensitivity, dizziness, loss of balance, elevated heart rate, severe fever and nausea. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills, body aches, heighten skin sensitivity, dizziness, loss of balance, elevated heart rate, severe fever and nausea was not recovered at the time of the report.  No follow-up attempts are possible; information about the lot number cannot be obtained.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Sensitive skin
Clinical narrative: Body aches; Heighten skin sensitivity; Nausea; Dizziness; Loss of balance; Elevated heart rate; Severe fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 15:00 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. Concomitant medications included drospirenone and ethinyl estradiol (GIANVI) from an unknown date for birth control. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Mar2021 at 15:00 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 02:00 the patient experienced chills, body aches, heighten skin sensitivity, dizziness, loss of balance, elevated heart rate, severe fever and nausea. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills, body aches, heighten skin sensitivity, dizziness, loss of balance, elevated heart rate, severe fever and nausea was not recovered at the time of the report.  No follow-up attempts are possible; information about the lot number cannot be obtained.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain, Vaccination site pain
Clinical narrative: Body ache; Fatigue; Soreness at injection site; This is a spontaneous report from a non-contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 01Apr2021 at 12:00 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 16:00, the patient experienced fatigue, body ache and soreness at injection site. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care The patient did not receive any treatment for the event. The clinical outcome of the event fatigue, body ache and soreness at injection site were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 02Apr2021 at 09:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Other medications in two weeks was reported as yes. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 02Apr2021 at 13:15, the patient experienced sore arm. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event sore arm was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood test, Dry mouth, Fatigue, Neck pain
Clinical narrative: Excruciating pain in neck; Mouth was extremely dry; Excruciating pain in shoulders.; Arms pain; Very tired; exhausted; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL9262) via an unspecified route of administration in the left arm on 28Jan2021 at 09:30 hours (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included ascorbic acid (VITAMIN C), vitamin d nos (VITAMIN D) and ascorbic acid (CALCIUM), all from unknown dates and for unknown indications. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Jan2021 at 08:00 hours (at the age of 65-years-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Feb2021 at 07:00 hours on or about day 4 after the second shot, the patient experienced excruciating pain in neck and shoulders, extremely dry mouth, exhausted(tired out), arms pain and very tired (tiredness). The patient reported that her mouth was extremely dry and sticking to her teeth. She never experienced anything like that and it was lasted well over a month, but the dryness let up somewhat. The pain in her neck and shoulder are worse some days than others. It did not go away at the time of report. She was also very tired and was exhausted. She always walked two miles and had trouble doing it. The patient did not receive any treatment for the reported events. The adverse events resulted in doctor or other healthcare professional office or clinic visit. The patient underwent lab tests which included blood test on an unknown date and the result was unknown. The clinical outcome of the event extremely dry mouth was recovered on an unknown date in 2021, while that of excruciating pain in neck, shoulders, arms pain, tired out and tiredness were not recovered at the time of this report.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Excruciating pain in neck; Mouth was extremely dry; Excruciating pain in shoulders.; Arms pain; Very tired; exhausted; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL9262) via an unspecified route of administration in the left arm on 28Jan2021 at 09:30 hours (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included ascorbic acid (VITAMIN C), vitamin d nos (VITAMIN D) and ascorbic acid (CALCIUM), all from unknown dates and for unknown indications. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Jan2021 at 08:00 hours (at the age of 65-years-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Feb2021 at 07:00 hours on or about day 4 after the second shot, the patient experienced excruciating pain in neck and shoulders, extremely dry mouth, exhausted(tired out), arms pain and very tired (tiredness). The patient reported that her mouth was extremely dry and sticking to her teeth. She never experienced anything like that and it was lasted well over a month, but the dryness let up somewhat. The pain in her neck and shoulder are worse some days than others. It did not go away at the time of report. She was also very tired and was exhausted. She always walked two miles and had trouble doing it. The patient did not receive any treatment for the reported events. The adverse events resulted in doctor or other healthcare professional office or clinic visit. The patient underwent lab tests which included blood test on an unknown date and the result was unknown. The clinical outcome of the event extremely dry mouth was recovered on an unknown date in 2021, while that of excruciating pain in neck, shoulders, arms pain, tired out and tiredness were not recovered at the time of this report.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Pyrexia
Clinical narrative: Fever; Chills; Fatigue; Muscle aches; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 01Apr2021 at 12:00 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included ulcerative colitis. The patient was allergic to sulpha drugs since an unknown date. Concomitant medications included minerals NOS, vitamins NOS (CENTRUM); calcium carbonate (CALTRATE); and levothyroxine sodium (SYNTHROID) all from an unknown date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 01Apr2021 at 22:00, the patient experienced fever, chills, fatigue and muscle aches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events fever, chills, fatigue and muscle aches were recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Malaise, Myalgia, Nausea
Clinical narrative: Injection site pain; Muscle ache; Tiredness; Injection site swelling and redness; Injection site swelling and redness; Headache; Nausea; Sick feeling; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: Ew0150) via an unspecified route of administration in the left arm on 31Mar2021 at 15:00 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes and COVID-19 on an unknown date. Concomitant medications were reported as no. The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 18:00, the patient experienced injection site pain, muscle ache, tiredness, injection site swelling and redness, headache, nausea and sick feeling. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events injection site pain, muscle ache, tiredness, injection site swelling and redness, headache, nausea and sick feeling were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Injection site pain; Muscle ache; Tiredness; Injection site swelling and redness; Injection site swelling and redness; Headache; Nausea; Sick feeling; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: Ew0150) via an unspecified route of administration in the left arm on 31Mar2021 at 15:00 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes and COVID-19 on an unknown date. Concomitant medications were reported as no. The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 18:00, the patient experienced injection site pain, muscle ache, tiredness, injection site swelling and redness, headache, nausea and sick feeling. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events injection site pain, muscle ache, tiredness, injection site swelling and redness, headache, nausea and sick feeling were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Urticaria
Clinical narrative: Broke out in shingles on the right side of lower trunk and lower back and right groin area in front; Breaking out in hives all over  trunk, neck and in hair; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Mar2021 at 00:00 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included caisson disease, peripheral neuropathy, joint replacement, generalised arthritis, headache, sciatica, drug allergy to Morphene, DHE for migraine. The patient received unspecified other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Mar2021 the patient experienced breaking out in hives all over trunk, neck and in hair. On 30Mar2021 the patient experienced broke out in shingles on the right side of lower trunk, lower back and right groin area in front. Roughly on 28Mar2021 began noticing that she was breaking out in hives all over her trunk, neck and in her hair. On the 30mar2021 she also broke out in shingles on the right side of her lower trunk, lower back and right groin area in front. The events resulted in Doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event and included treatment with medications for pain, steroid salve, steroid pills. The clinical outcome of the event breaking out in hives all over trunk, neck and in hair and broke out in shingles on the right side of lower trunk, lower back and right groin area in front was resolving.   No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Inflammation, Lymphadenopathy, Pain, Pruritus
Clinical narrative: Inflamed swollen area; Funny taste in mouth; 102.7 fever 2 days; Swollen sore lymph nodes under arm; Swollen red rash on arm; Redness started at injection site little below shoulder and has spread to elbow; sore to touch; itchy; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 30Mar2021 at 13:30 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes and asthma. The patient had history of allergy to cheyenne pepper, almonds, pomegranate seasonal allergies. Concomitant medications included metformin (MANUFACTURER UNKNOWN), fexofenadine hydrochloride (ALLEGRA) and fluticasone propionate (FLONASE), all from unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 09Mar2021 at 12:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 08:30, the patient experienced 102.7 fever 2 days, swollen sore lymph nodes under arm, swollen red rash on arm. Redness started at injection site (little below shoulder) and since Tuesday had spread too elbow. The inflamed swollen area was warm, sore to touch, and itchy. A funny taste in mouth. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of reported events and included treatment with ice area and ibuprofen (MOTRIN). The clinical outcomes of 102.7 fever 2 days, swollen sore lymph nodes, swollen red rash, redness at injection site, inflamed swollen area was warm, sore to touch, and itchy, funny taste in mouth were not resolved.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash erythematous, Taste disorder, Vaccination site erythema
Clinical narrative: Inflamed swollen area; Funny taste in mouth; 102.7 fever 2 days; Swollen sore lymph nodes under arm; Swollen red rash on arm; Redness started at injection site little below shoulder and has spread to elbow; sore to touch; itchy; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 30Mar2021 at 13:30 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes and asthma. The patient had history of allergy to cheyenne pepper, almonds, pomegranate seasonal allergies. Concomitant medications included metformin (MANUFACTURER UNKNOWN), fexofenadine hydrochloride (ALLEGRA) and fluticasone propionate (FLONASE), all from unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 09Mar2021 at 12:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 08:30, the patient experienced 102.7 fever 2 days, swollen sore lymph nodes under arm, swollen red rash on arm. Redness started at injection site (little below shoulder) and since Tuesday had spread too elbow. The inflamed swollen area was warm, sore to touch, and itchy. A funny taste in mouth. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of reported events and included treatment with ice area and ibuprofen (MOTRIN). The clinical outcomes of 102.7 fever 2 days, swollen sore lymph nodes, swollen red rash, redness at injection site, inflamed swollen area was warm, sore to touch, and itchy, funny taste in mouth were not resolved.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.